| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,422 |
31,387 |
$6.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
19,841 |
18,082 |
$5.63M |
| G0378 |
Hospital observation service, per hour |
11,446 |
6,549 |
$3.97M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
31,868 |
29,953 |
$3.91M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
21,626 |
19,153 |
$1.85M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
26,662 |
23,562 |
$1.49M |
| 71046 |
Radiologic examination, chest; 2 views |
23,453 |
22,056 |
$792K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,777 |
5,597 |
$772K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,088 |
2,078 |
$680K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
21,896 |
16,895 |
$628K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,832 |
5,529 |
$511K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,094 |
14,390 |
$507K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,699 |
6,493 |
$503K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
6,619 |
5,095 |
$476K |
| 80061 |
Lipid panel |
13,376 |
13,215 |
$429K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,687 |
5,552 |
$413K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
19,789 |
5,109 |
$363K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,378 |
2,353 |
$343K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,054 |
5,827 |
$291K |
| 59025 |
Fetal non-stress test |
3,416 |
2,477 |
$284K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
504 |
497 |
$250K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
17,342 |
4,653 |
$247K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,330 |
2,291 |
$240K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
11,491 |
3,288 |
$231K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,438 |
4,432 |
$213K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,534 |
1,482 |
$198K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
938 |
929 |
$183K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,323 |
3,230 |
$177K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
448 |
446 |
$177K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
483 |
465 |
$164K |
| 76801 |
|
2,874 |
2,592 |
$164K |
| 93975 |
|
1,471 |
1,439 |
$163K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,461 |
2,390 |
$149K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,810 |
1,766 |
$148K |
| 80053 |
Comprehensive metabolic panel |
55,941 |
48,622 |
$139K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,721 |
5,467 |
$127K |
| 84443 |
Thyroid stimulating hormone (TSH) |
15,929 |
15,676 |
$126K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,318 |
2,248 |
$122K |
| 76830 |
Ultrasound, transvaginal |
2,129 |
2,090 |
$118K |
| 47562 |
|
67 |
67 |
$116K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,569 |
1,557 |
$116K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
7,446 |
7,392 |
$114K |
| 94060 |
|
952 |
897 |
$111K |
| 71045 |
Radiologic examination, chest; single view |
3,513 |
3,347 |
$110K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
62,619 |
52,048 |
$109K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,656 |
2,432 |
$109K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
284 |
283 |
$106K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,067 |
1,060 |
$97K |
| 97161 |
|
1,951 |
1,928 |
$93K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,829 |
1,813 |
$83K |
| 97162 |
|
1,511 |
1,495 |
$77K |
| 93971 |
|
1,490 |
1,465 |
$76K |
| 76770 |
|
1,414 |
1,391 |
$74K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
607 |
593 |
$72K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,820 |
3,764 |
$61K |
| 77066 |
Tomosynthesis, mammo |
1,052 |
1,046 |
$57K |
| 76536 |
|
1,124 |
1,121 |
$54K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,549 |
3,496 |
$54K |
| 20611 |
|
351 |
306 |
$49K |
| 72141 |
|
357 |
354 |
$49K |
| 97597 |
|
734 |
367 |
$48K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
90 |
90 |
$46K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,844 |
9,744 |
$46K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
369 |
359 |
$43K |
| 77065 |
Tomosynthesis, mammo |
991 |
968 |
$41K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
977 |
271 |
$39K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,834 |
17,232 |
$39K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
158 |
157 |
$39K |
| 76642 |
|
971 |
957 |
$37K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,648 |
3,384 |
$35K |
| 84439 |
|
7,570 |
7,471 |
$34K |
| 72100 |
|
2,282 |
2,236 |
$30K |
| 76641 |
|
576 |
565 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,959 |
4,830 |
$27K |
| 74018 |
|
5,255 |
4,913 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,621 |
4,525 |
$25K |
| 82607 |
|
3,371 |
3,343 |
$23K |
| 82728 |
|
3,048 |
2,990 |
$21K |
| 29515 |
|
293 |
287 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,773 |
8,334 |
$20K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
80 |
80 |
$19K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
119 |
76 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,271 |
11,391 |
$19K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
321 |
309 |
$17K |
| 83970 |
|
801 |
795 |
$17K |
| 83735 |
|
14,988 |
13,037 |
$17K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,330 |
1,328 |
$16K |
| 84702 |
|
3,980 |
3,111 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,609 |
7,245 |
$16K |
| 10060 |
|
187 |
183 |
$16K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
27 |
25 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,447 |
1,424 |
$15K |
| 73562 |
|
2,818 |
2,712 |
$15K |
| 71271 |
|
260 |
260 |
$15K |
| 85027 |
|
5,305 |
4,959 |
$15K |
| 73610 |
|
2,440 |
2,311 |
$15K |
| 83880 |
|
3,337 |
3,147 |
$14K |
| 72050 |
|
551 |
546 |
$14K |
| 82746 |
|
1,972 |
1,957 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
839 |
824 |
$14K |
| 93880 |
|
172 |
172 |
$14K |
| 86003 |
|
284 |
282 |
$14K |
| 73030 |
|
2,151 |
2,089 |
$14K |
| 84484 |
|
14,293 |
10,866 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,543 |
1,422 |
$13K |
| 80074 |
|
654 |
643 |
$13K |
| 73630 |
|
2,284 |
2,246 |
$13K |
| 80306 |
|
7,040 |
6,543 |
$12K |
| 83516 |
|
913 |
711 |
$12K |
| 72110 |
|
464 |
462 |
$12K |
| 83550 |
|
2,641 |
2,592 |
$11K |
| 87186 |
|
3,773 |
3,651 |
$11K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
600 |
199 |
$11K |
| 83540 |
|
3,148 |
3,088 |
$10K |
| 87077 |
|
3,773 |
3,651 |
$10K |
| 85730 |
|
14,414 |
12,887 |
$10K |
| 93458 |
|
13 |
13 |
$10K |
| 84481 |
|
1,174 |
1,163 |
$10K |
| 87070 |
|
3,792 |
3,658 |
$10K |
| 81025 |
|
13,846 |
12,879 |
$10K |
| 71250 |
|
179 |
179 |
$9K |
| 83605 |
|
8,269 |
7,404 |
$9K |
| 83690 |
|
14,900 |
13,075 |
$9K |
| 85610 |
|
15,971 |
14,363 |
$9K |
| 73221 |
|
79 |
76 |
$9K |
| 82947 |
|
510 |
481 |
$9K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
873 |
868 |
$9K |
| 93017 |
|
271 |
266 |
$8K |
| 81001 |
|
19,214 |
17,710 |
$8K |
| 73130 |
|
1,962 |
1,918 |
$8K |
| 86140 |
|
4,446 |
3,907 |
$8K |
| 70486 |
|
370 |
363 |
$8K |
| 87634 |
|
1,477 |
1,426 |
$8K |
| 73110 |
|
1,230 |
1,169 |
$8K |
| 87390 |
|
657 |
652 |
$8K |
| 73502 |
|
886 |
871 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
59,834 |
51,629 |
$7K |
| 86038 |
|
1,231 |
1,223 |
$7K |
| 62323 |
|
26 |
24 |
$7K |
| 86900 |
|
3,654 |
3,449 |
$7K |
| 96367 |
|
399 |
310 |
$7K |
| 77080 |
|
114 |
114 |
$7K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
28 |
28 |
$6K |
| 82565 |
|
3,177 |
2,820 |
$6K |
| 82150 |
|
9,484 |
8,580 |
$6K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$6K |
| 84425 |
|
537 |
531 |
$6K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
38 |
34 |
$6K |
| 86850 |
|
2,621 |
2,499 |
$6K |
| 70496 |
|
40 |
37 |
$5K |
| 72131 |
|
129 |
127 |
$5K |
| 72040 |
|
13 |
12 |
$5K |
| 96376 |
|
9,557 |
5,199 |
$5K |
| 86803 |
|
565 |
564 |
$4K |
| 84100 |
|
3,211 |
2,832 |
$4K |
| 84403 |
|
327 |
325 |
$4K |
| 84520 |
|
2,395 |
2,215 |
$4K |
| 82570 |
|
1,514 |
1,433 |
$4K |
| 80076 |
|
995 |
891 |
$4K |
| 85652 |
|
3,406 |
2,976 |
$4K |
| 82550 |
|
4,717 |
3,855 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$4K |
| 85379 |
|
4,483 |
4,299 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
276 |
272 |
$4K |
| 84460 |
|
1,281 |
1,207 |
$3K |
| 84450 |
|
1,271 |
1,193 |
$3K |
| 84550 |
|
1,448 |
1,367 |
$3K |
| 84153 |
|
339 |
333 |
$3K |
| 87081 |
|
2,615 |
2,590 |
$3K |
| 80051 |
|
994 |
928 |
$3K |
| 81003 |
|
10,072 |
9,488 |
$3K |
| 86780 |
|
369 |
367 |
$3K |
| 87205 |
|
2,086 |
1,981 |
$3K |
| 84134 |
|
322 |
297 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
248 |
248 |
$2K |
| 87040 |
|
3,172 |
2,712 |
$2K |
| 73140 |
|
238 |
221 |
$2K |
| 86901 |
|
3,640 |
3,435 |
$2K |
| 78226 |
|
12 |
12 |
$2K |
| 99406 |
|
154 |
153 |
$2K |
| 84255 |
|
151 |
151 |
$2K |
| 88304 |
|
788 |
778 |
$2K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
54 |
54 |
$2K |
| 73100 |
|
120 |
104 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
82 |
80 |
$2K |
| 82043 |
|
634 |
633 |
$2K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
12 |
12 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
28 |
26 |
$2K |
| 82248 |
|
594 |
424 |
$2K |
| 73560 |
|
86 |
79 |
$1K |
| 86431 |
|
483 |
482 |
$1K |
| 83615 |
|
670 |
618 |
$1K |
| 84630 |
|
197 |
195 |
$1K |
| 90686 |
|
73 |
73 |
$1K |
| 87340 |
|
243 |
235 |
$1K |
| 73080 |
|
277 |
272 |
$1K |
| 83001 |
|
106 |
105 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
42 |
42 |
$1K |
| 82525 |
|
168 |
168 |
$1K |
| 82785 |
|
144 |
143 |
$1K |
| 97035 |
|
195 |
73 |
$1K |
| 93351 |
|
13 |
12 |
$1K |
| 84590 |
|
164 |
163 |
$983.52 |
| 95816 |
|
12 |
12 |
$937.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
8,864 |
4,617 |
$920.39 |
| 72170 |
|
665 |
657 |
$903.85 |
| 84112 |
|
15 |
15 |
$845.78 |
| 82075 |
|
4,010 |
3,491 |
$820.24 |
| 83655 |
|
124 |
120 |
$736.69 |
| 73590 |
|
257 |
245 |
$698.29 |
| 86665 |
|
45 |
43 |
$690.56 |
| 84703 |
|
448 |
442 |
$639.00 |
| 82247 |
|
204 |
121 |
$614.88 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
536 |
480 |
$565.22 |
| 87529 |
|
25 |
24 |
$562.25 |
| 70498 |
|
27 |
24 |
$550.59 |
| 83002 |
|
63 |
63 |
$538.99 |
| 74019 |
|
49 |
49 |
$518.23 |
| 70491 |
|
12 |
12 |
$511.40 |
| 73090 |
|
247 |
231 |
$504.22 |
| 82533 |
|
56 |
51 |
$500.64 |
| 71101 |
|
25 |
25 |
$477.05 |
| 88108 |
|
53 |
52 |
$475.67 |
| 87046 |
|
57 |
57 |
$471.64 |
| 82784 |
|
58 |
58 |
$376.67 |
| 80143 |
|
412 |
404 |
$349.22 |
| 80179 |
|
351 |
348 |
$333.78 |
| 86664 |
|
41 |
41 |
$290.94 |
| 72070 |
|
12 |
12 |
$286.50 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,218 |
10,543 |
$281.27 |
| 80164 |
|
70 |
67 |
$276.10 |
| 86225 |
|
50 |
49 |
$269.26 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
14 |
12 |
$262.76 |
| 82140 |
|
37 |
37 |
$258.25 |
| 86663 |
|
42 |
42 |
$249.60 |
| 82105 |
|
27 |
26 |
$246.85 |
| 87045 |
|
57 |
57 |
$246.10 |
| 84402 |
|
13 |
13 |
$245.93 |
| 82272 |
|
288 |
273 |
$239.33 |
| 73120 |
|
12 |
12 |
$228.16 |
| 70360 |
|
42 |
42 |
$213.86 |
| 86376 |
|
27 |
27 |
$209.52 |
| 87430 |
|
1,920 |
1,896 |
$206.03 |
| G0008 |
Administration of influenza virus vaccine |
38 |
38 |
$192.42 |
| 87498 |
|
12 |
12 |
$189.32 |
| 84156 |
|
100 |
87 |
$187.77 |
| 87808 |
|
571 |
566 |
$157.97 |
| 87324 |
|
15 |
15 |
$133.65 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
259 |
251 |
$132.33 |
| 74022 |
|
27 |
27 |
$114.08 |
| 12001 |
|
381 |
371 |
$106.59 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
41 |
38 |
$101.25 |
| 86762 |
|
12 |
12 |
$84.24 |
| 83721 |
|
15 |
15 |
$78.12 |
| 94726 |
|
334 |
323 |
$71.27 |
| 29125 |
|
245 |
232 |
$64.79 |
| 88342 |
|
53 |
53 |
$63.96 |
| 87075 |
|
27 |
25 |
$58.99 |
| 83520 |
|
666 |
613 |
$48.62 |
| 94760 |
|
706 |
493 |
$31.46 |
| 90715 |
|
1,225 |
1,213 |
$28.69 |
| 94729 |
|
322 |
312 |
$24.02 |
| 84145 |
|
39 |
35 |
$17.93 |
| 82009 |
|
210 |
163 |
$17.74 |
| 84132 |
|
14 |
14 |
$15.25 |
| 80178 |
|
12 |
12 |
$14.52 |
| 89050 |
|
16 |
16 |
$13.84 |
| 84157 |
|
12 |
12 |
$10.72 |
| 85045 |
|
15 |
12 |
$9.43 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
251 |
211 |
$7.50 |
| 86308 |
|
26 |
25 |
$6.82 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
355 |
284 |
$5.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,117 |
3,248 |
$4.16 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,999 |
4,166 |
$4.03 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,218 |
2,404 |
$4.02 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,237 |
1,184 |
$2.81 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16,685 |
14,462 |
$1.66 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,487 |
1,458 |
$0.79 |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,144 |
3,399 |
$0.75 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,663 |
8,239 |
$0.58 |
| J2704 |
Injection, propofol, 10 mg |
9,678 |
9,388 |
$0.39 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,374 |
7,873 |
$0.19 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,529 |
5,934 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17,761 |
14,648 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
464 |
244 |
$0.00 |
| 76942 |
|
56 |
56 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
377 |
329 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,923 |
1,891 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
91 |
91 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
3,467 |
2,254 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
279 |
250 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
302 |
147 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
460 |
445 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
107 |
94 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
100 |
88 |
$0.00 |
| 12011 |
|
27 |
26 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
312 |
252 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
100 |
99 |
$0.00 |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
369 |
356 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
27 |
25 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
26 |
24 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
333 |
202 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
14 |
14 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
14 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,435 |
2,969 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,186 |
406 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,978 |
3,275 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,949 |
2,886 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
806 |
778 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
941 |
915 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,791 |
7,311 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
142 |
139 |
$0.00 |
| C1769 |
Guide wire |
724 |
694 |
$0.00 |
| J3490 |
Unclassified drugs |
969 |
814 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
4,049 |
2,903 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
10,433 |
6,699 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,674 |
1,618 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
343 |
326 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
123 |
120 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
72 |
71 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
228 |
220 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
239 |
194 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
13 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
42 |
39 |
$0.00 |
| 76870 |
|
64 |
64 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
160 |
157 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
72 |
70 |
$0.00 |
| 82553 |
|
2,337 |
1,636 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
271 |
170 |
$0.00 |
| 12002 |
|
63 |
60 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
123 |
117 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
45 |
41 |
$0.00 |